Kamal Kant Mangla

Prognostic utility of Fibrosis-4 Index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and/or type 2 diabetes: a longitudinal cohort study

Quentin M. Anstee, Tina Landsvig Berentzen, Louise Maymann Nitze et al. · The Lancet Regional Health - Europe · 2023 · 107 citations · Full text

Medicine, Pathology, Clinical Epidemiology +16

Smart controller for conical tank system using reinforcement learning algorithm

Prabhu Ramanathan, Kamal Kant Mangla, Sitanshu Satpathy · Measurement · 2017 · 36 citations

Engineering, Marine Engineering, Markov Decision Processes +12

Improved health‐related quality of life with semaglutide in people with non‐alcoholic steatohepatitis: A randomised trial

Manuel Romero‐Gómez, Matthew J. Armstrong, Jesús Funuyet‐Salas et al. · Alimentary Pharmacology & Therapeutics · 2023 · 26 citations · Full text

Medicine, Internal Medicine, Pharmacology +6

Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction–associated steatohepatitis

Zobair M. Younossi, Kamal Kant Mangla, Tina Landsvig Berentzen et al. · Hepatology Communications · 2024 · 22 citations · Full text

Medicine, Internal Medicine, Pathology +17

Estimating the economic impact of comorbidities in patients with MASH and defining high-cost burden in patients with noncirrhotic MASH

Zobair M. Younossi, Kamal Kant Mangla, Abhishek Shankar Chandramouli et al. · Hepatology Communications · 2024 · 13 citations · Full text

Medicine, Internal Medicine, Pharmacoeconomics +17